Literature DB >> 18435425

The combination of methamphetamine and of the HIV protein, Tat, induces death of the human neuroblastoma cell line, SH-SY5Y.

Ning Sheng Cai1, Jean Lud Cadet.   

Abstract

Human immunodeficiency virus (HIV)-infected methamphetamine (METH) abusers show greater neuropathological abnormalities than HIV-negative METH abusers or HIV-positive non-METH users. Herein, we investigated the effects of METH and of the HIV protein, Tat, using the human neuroblastoma cell line, SHY5Y. METH and Tat alone caused no toxic effects. In contrast, the combination of METH and Tat caused significant increases in the percentage of dead cells observed after 48 h of exposure. These results suggest the possibility of using this model to elucidate cellular and molecular mechanisms involved in the potentiation of clinical effects observed in patient populations of HIV-positive METH-abusing patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18435425     DOI: 10.1002/syn.20512

Source DB:  PubMed          Journal:  Synapse        ISSN: 0887-4476            Impact factor:   2.562


  10 in total

1.  Substance Abuse, Hepatitis C, and Aging in HIV: Common Cofactors that Contribute to Neurobehavioral Disturbances.

Authors:  Randi Melissa Schuster; Raul Gonzalez
Journal:  Neurobehav HIV Med       Date:  2012-02-16

2.  D1/NMDA receptors and concurrent methamphetamine+ HIV-1 Tat neurotoxicity.

Authors:  Michael Y Aksenov; M V Aksenova; C F Mactutus; Rosemarie M Booze
Journal:  J Neuroimmune Pharmacol       Date:  2012-05-03       Impact factor: 4.147

3.  The synthetic opioid fentanyl increases HIV replication and chemokine co-receptor expression in vitro.

Authors:  Ling Kong; Mohamed Tarek M Shata; Jennifer L Brown; Michael S Lyons; Kenneth E Sherman; Jason T Blackard
Journal:  J Neurovirol       Date:  2022-08-17       Impact factor: 3.739

4.  Keto amphetamine toxicity-focus on the redox reactivity of the cathinone designer drug mephedrone.

Authors:  Bjørnar den Hollander; Mira Sundström; Anna Pelander; Ilkka Ojanperä; Eero Mervaala; Esa Risto Korpi; Esko Kankuri
Journal:  Toxicol Sci       Date:  2014-06-09       Impact factor: 4.849

5.  HIV-1 Tat increases BAG3 via NF-κB signaling to induce autophagy during HIV-associated neurocognitive disorder.

Authors:  Xiaoyan Wu; Huaqian Dong; Xiang Ye; Li Zhong; Tiantian Cao; Qiping Xu; Jun Wang; Yu Zhang; Jinhong Xu; Wei Wang; Qiang Wei; Ying Liu; Shuhui Wang; Yiming Shao; Huiqin Xing
Journal:  Cell Cycle       Date:  2018-08-21       Impact factor: 4.534

Review 6.  Role of Tat protein in HIV neuropathogenesis.

Authors:  Wenxue Li; Guanhan Li; Joseph Steiner; Avindra Nath
Journal:  Neurotox Res       Date:  2009-03-21       Impact factor: 3.911

Review 7.  Drugs of Abuse and Their Impact on Viral Pathogenesis.

Authors:  Jason T Blackard; Kenneth E Sherman
Journal:  Viruses       Date:  2021-11-29       Impact factor: 5.048

8.  The protective effect of gastrodin against the synergistic effect of HIV-Tat protein and METH on the blood-brain barrier via glucose transporter 1 and glucose transporter 3.

Authors:  Juan Li; Jian Huang; Yongwang He; Wenguang Wang; Chi-Kwan Leung; Dongxian Zhang; Ruilin Zhang; Shangwen Wang; Yuanyuan Li; Liu Liu; Xiaofeng Zeng; Zhen Li
Journal:  Toxicol Res (Camb)       Date:  2021-01-22       Impact factor: 3.524

Review 9.  The cross-talk of HIV-1 Tat and methamphetamine in HIV-associated neurocognitive disorders.

Authors:  Sonia Mediouni; Maria Cecilia Garibaldi Marcondes; Courtney Miller; Jay P McLaughlin; Susana T Valente
Journal:  Front Microbiol       Date:  2015-10-23       Impact factor: 5.640

Review 10.  HIV-1, methamphetamine and astrocytes at neuroinflammatory Crossroads.

Authors:  Kathleen Borgmann; Anuja Ghorpade
Journal:  Front Microbiol       Date:  2015-10-27       Impact factor: 5.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.